QIM
RGLS

Quantitative Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Quantitative Investment Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-382
Closed -$47K – 893
2017
Q4 		$47K Sell
382
-1,101
-74% -$139K ﹤0.01% 734
2017
Q3 		$222K Buy
1,483
+608
+69% +$76.5K ﹤0.01% 651
2017
Q2 		$103K Buy
+875
New +$146K ﹤0.01% 663
2015
Q4 		– Sell
-141
Closed -$110K – 819
2015
Q3 		$110K Buy
141
+17
+14% +$17.4K 0.01% 636
2015
Q2 		$163K Buy
+124
New +$200K 0.02% 400

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return